
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16776508
[patent_doc_number] => 20210113585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHODS FOR TREATING CHOLESTASIS
[patent_app_type] => utility
[patent_app_number] => 17/119132
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119132 | Methods for treating cholestasis | Dec 10, 2020 | Issued |
Array
(
[id] => 18226815
[patent_doc_number] => 20230065809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TRICYCLIC COMPOUNDS WITH OMA1/OPA1 MODULATORY PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/784239
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784239 | Tricyclic compounds with OMA1/OPA1 modulatory properties | Dec 8, 2020 | Issued |
Array
(
[id] => 16900617
[patent_doc_number] => 20210179533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/105948
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105948 | Salicyl fumarate derivative and its application in the treatment of Parkinson's disease and other neurodegenerative diseases | Nov 26, 2020 | Issued |
Array
(
[id] => 18312201
[patent_doc_number] => 20230116101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/776952
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -315
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776952 | Compounds and uses thereof | Nov 12, 2020 | Issued |
Array
(
[id] => 18492226
[patent_doc_number] => 11697636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Substituted benzamides
[patent_app_type] => utility
[patent_app_number] => 17/096438
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29258
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096438 | Substituted benzamides | Nov 11, 2020 | Issued |
Array
(
[id] => 18036113
[patent_doc_number] => 20220380328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => RECYCLE CONTENT ETHYLENE OXIDE OR ALKYLENE GLYCOLS
[patent_app_type] => utility
[patent_app_number] => 17/755341
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755341 | RECYCLE CONTENT ETHYLENE OXIDE OR ALKYLENE GLYCOLS | Nov 5, 2020 | Pending |
Array
(
[id] => 19067101
[patent_doc_number] => 20240101527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => QUINOLONE CARBOXYLIC DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/754703
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754703 | QUINOLONE CARBOXYLIC DERIVATIVES | Oct 22, 2020 | Pending |
Array
(
[id] => 17022258
[patent_doc_number] => 20210246129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/075583
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075583 | Benzoxazepin oxazolidinone compounds and methods of use | Oct 19, 2020 | Issued |
Array
(
[id] => 18451414
[patent_doc_number] => 20230192692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/754924
[patent_app_country] => US
[patent_app_date] => 2020-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 379
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754924 | MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF | Oct 9, 2020 | Pending |
Array
(
[id] => 16613579
[patent_doc_number] => 20210032232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => CRYSTALLINE SALTS OF PEPTIDE EPOXYKETONE IMMUNOPROTEASOME INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/066556
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -87
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066556 | Crystalline salts of peptide epoxyketone immunoproteasome inhibitor | Oct 8, 2020 | Issued |
Array
(
[id] => 20115973
[patent_doc_number] => 12365662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Process for 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one
[patent_app_type] => utility
[patent_app_number] => 17/761868
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761868 | Process for 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one | Oct 7, 2020 | Issued |
Array
(
[id] => 18093026
[patent_doc_number] => 20220411367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
[patent_app_type] => utility
[patent_app_number] => 17/766889
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766889 | ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS | Oct 5, 2020 | Pending |
Array
(
[id] => 20143856
[patent_doc_number] => 12378183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Process for preparing glycerol carbonate (meth)acrylate
[patent_app_type] => utility
[patent_app_number] => 17/755100
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755100 | Process for preparing glycerol carbonate (meth)acrylate | Oct 1, 2020 | Issued |
Array
(
[id] => 20756976
[patent_doc_number] => 12649735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Compound having BRD4 inhibitory activity, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/766601
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36650
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 400
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766601 | Compound having BRD4 inhibitory activity, preparation method therefor and use thereof | Sep 23, 2020 | Issued |
Array
(
[id] => 18018807
[patent_doc_number] => 20220370306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SILICONE DROPLETS
[patent_app_type] => utility
[patent_app_number] => 17/763073
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763073 | SILICONE DROPLETS | Sep 21, 2020 | Abandoned |
Array
(
[id] => 18077261
[patent_doc_number] => 20220402873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/761830
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761830 | NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES | Sep 20, 2020 | Pending |
Array
(
[id] => 18036099
[patent_doc_number] => 20220380314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/760878
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -102
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760878 | SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | Sep 16, 2020 | Abandoned |
Array
(
[id] => 18701297
[patent_doc_number] => 11787796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Plasma Kallikrein inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/024437
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77444
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 668
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024437 | Plasma Kallikrein inhibitors and uses thereof | Sep 16, 2020 | Issued |
Array
(
[id] => 17990140
[patent_doc_number] => 20220356177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/642629
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642629 | Thyroid hormone receptor beta agonist compounds | Sep 10, 2020 | Issued |
Array
(
[id] => 17067243
[patent_doc_number] => 20210269458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/015171
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 176435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015171 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | Sep 8, 2020 | Abandoned |